Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score

J Cardiovasc Transl Res. 2021 Dec;14(6):1125-1130. doi: 10.1007/s12265-021-10122-y. Epub 2021 Mar 22.

Abstract

We evaluated the predictive power of age, creatinine, and ejection fraction (ACEF) score on mortality at 5-year follow-up in a population of 471 patients with chronic coronary syndrome (CCS) treated with percutaneous coronary intervention (PCI). Patients in the ACEF-High tertile showed the highest incidence of death at 5 years (15.7% vs. 2.6% in ACEF-Low and 4.3% in ACEF-Mid; log rank p<0.001). The ACEF score could significantly discriminate between patients who died and those who were still alive at 5 years (AUC 0.741, 95% CI 0.654-0.828), and an ACEF score >1.32 was identified as the optimal cutoff point to predict 5-year mortality (sensitivity 74%, specificity 68%). An ACEF score >1.32 was an independent predictor of 5-year mortality (HR 5.77, 95% CI 2.70-12.31; p<0.001). Our study shows that the ACEF score can predict mortality at 5-year follow-up in patients with CCS treated with PCI.

Keywords: ACEF score; Chronic coronary syndrome; Percutaneous coronary intervention.

MeSH terms

  • Age Factors
  • Aged
  • Biomarkers / blood
  • Chronic Disease
  • Coronary Angiography
  • Coronary Disease / mortality*
  • Coronary Disease / surgery*
  • Creatinine / blood
  • Female
  • Humans
  • Italy
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention*
  • Prognosis
  • Prospective Studies
  • Stroke Volume
  • Syndrome

Substances

  • Biomarkers
  • Creatinine